Malaria, Vivax

9 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Infections, Malaria

Treatments and conditions

Malaria, Vivax
Treatment and conditionWhere it standsTrials
Artemether + Lumefantrine for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Artemether + Lumefantrine + TAFENOQUINE for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin + Piperaquine tetraphosphate for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin + Piperaquine tetraphosphate + TAFENOQUINE for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Primaquine for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Pvs230D1-EPA/Matrix-M for malaria, vivaxTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tafenoquine for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Tafenoquine + chloroquine for malaria, vivaxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tafenoquine succinate for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.